Aspen Pharmacare Holdings Ltd

LDZA

Company Profile

  • Business description

    Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) – this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin – this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

  • Contact

    Douglas Saunders Drive
    Aspen Place
    9 Rydall Vale Park
    La Lucia Ridge
    DurbanNL
    ZAF

    T: +27 315808600

    https://www.aspenpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    30 June 2025

    Employees

    9,350

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,148.9093.601.16%
CAC 408,094.2077.27-0.95%
DAX 4022,999.15288.91-1.24%
Dow JONES (US)41,953.3211.31-0.03%
FTSE 1008,701.994.67-0.05%
HKSE24,219.95551.19-2.23%
NASDAQ17,691.6359.16-0.33%
Nikkei 22537,751.8893.54-0.25%
NZX 50 Index12,107.9553.230.44%
S&P 5005,662.8912.40-0.22%
S&P/ASX 2007,918.9090.601.16%
SSE Composite Index3,408.9517.48-0.51%

Market Movers